Rigel Pharmaceuticals
RIGL
RIGL
110 hedge funds and large institutions have $299M invested in Rigel Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 43 increasing their positions, 31 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.11% more ownership
Funds ownership: 8.83% → 8.94% (+0.11%)
16% less capital invested
Capital invested by funds: $357M → $299M (-$57.1M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
110
Holding in Top 10
1
Calls
$308K
Puts
$107K
Top Buyers
| 1 | +$5.14M | |
| 2 | +$2.32M | |
| 3 | +$1.29M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$952K |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$842K |
Top Sellers
| 1 | -$1.97M | |
| 2 | -$1.48M | |
| 3 | -$1.34M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.32M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$1.26M |